This inventor holds 2 USPTO granted patents. Top assignees: Glaxo Group Limited, Glaxo Wellcome Inc.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Peter John Sharratt: Innovator in Pharmaceutical Compounds
Introduction: Peter John Sharratt is a prominent inventor based in Stevenage, Great Britain, known for his contributions to pharmaceutical research. With two patents to his name, he has significantly impacted the field of medicinal chemistry.
Latest Patents: His latest inventions involve piperidine derivatives exhibiting tachykinin antagonist activity. Specifically, he has developed 3-benzylamino-2-phenylpiperidines as neurokinin antagonists, showcasing his dedication to advancing therapeutic options.
Career Highlights: Sharratt has a notable career, having worked with prestigious companies like Glaxo Wellcome Inc. and Glaxo Group Limited. His tenure at these organizations underlined his role in innovative drug development and research.
Collaborations: Throughout his career, Sharratt has collaborated with esteemed colleagues, including Gerard Martin Giblin and Duncan Robert Armour. These partnerships have fostered an environment of creativity and innovation in the pharmaceutical industry.
Conclusion: Peter John Sharratt's contributions to the field of pharmaceuticals through his patents and collaborations are commendable. His work continues to influence the development of new therapeutic agents, reflecting his commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile